Furthermore, as CREB3L1 silencing has been observed in lung squamous cell carcinoma, colon, adrenal gland, rectum, cervix, and liver cancers, the findings from this study may have broader implications beyond TNBC [31]. This evidence concerns the gene CREB3L1 and squamous cell lung carcinoma.